Gemfrac 600mcg Injection

Gemfrac 600mcg injection contains an active component called teriparatide, which belongs to a group of parathyroid hormone (PTH) drugs. It is used to treat osteoporosis in adults. It is a condition marked by weakened bones, heightening the likelihood of fractures. It strengthens the bone and promotes the creation of new bone tissue in individuals. It is used to postmenopausal women with osteoporosis, increase bone mass in primary or hypogonadal osteoporosis men, and also to treat both men and women with osteoporosis associated with sustained systemic glucocorticoid therapy.